Study shows new signaling pathway of hematopoietic stem cells

03/27/2009 | Xinhuanet.com (China)

U.S. researchers have discovered that blood-forming stem cells without a signaling molecule called GalphaS were unable to engraft in the bone marrow of mice. The finding may help increase the effectiveness of bone marrow transplants by treating bone marrow cells with GalphaS pathway activators.

View Full Article in:

Xinhuanet.com (China)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY